These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The continuing evolution of torsades de pointes liability testing methods: is there an end in sight? Lee N, Authier S, Pugsley MK, Curtis MJ. Toxicol Appl Pharmacol; 2010 Mar 01; 243(2):146-53. PubMed ID: 20005885 [Abstract] [Full Text] [Related]
26. A step towards characterisation of electrophysiological profile of torsadogenic drugs. Champeroux P, Ouillé A, Martel E, Fowler JS, Maurin A, Richard S, Le Guennec JY. J Pharmacol Toxicol Methods; 2011 Mar 01; 63(3):269-78. PubMed ID: 21224008 [Abstract] [Full Text] [Related]
27. Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres. Puisieux FL, Adamantidis MM, Dumotier BM, Dupuis BA. Br J Pharmacol; 1996 Apr 01; 117(7):1377-9. PubMed ID: 8730728 [Abstract] [Full Text] [Related]
31. Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance. Adamantidis MM, Lacroix DL, Caron JF, Dupuis BA. J Cardiovasc Pharmacol; 1995 Aug 01; 26(2):319-27. PubMed ID: 7475058 [Abstract] [Full Text] [Related]
32. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists. Gilbert JD, Cahill SA, McCartney DG, Lukas A, Gross GJ. Can J Physiol Pharmacol; 2000 May 01; 78(5):407-14. PubMed ID: 10841436 [Abstract] [Full Text] [Related]
38. Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig. Guns PJ, Johnson DM, Weltens E, Lissens J. J Pharmacol Toxicol Methods; 2012 Sep 01; 66(2):125-34. PubMed ID: 22516473 [Abstract] [Full Text] [Related]